Anticancer platinum (IV) prodrugs with novel modes of activity.
about
Advances in drug delivery system for platinum agents based combination therapyCarbon nanotubes as cancer therapeutic carriers and mediatorsAn albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo.Induction of targeted necrosis with HER2-targeted platinum(iv) anticancer prodrugs.Encapsulation of Pt(IV) Prodrugs within a Pt(II) Cage for Drug Delivery.Targeting and delivery of platinum-based anticancer drugs.Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.Multifunctional platinum-based nanoparticles for biomedical applications.Oral delivery of a platinum anticancer drug using lipid assisted polymeric nanoparticles.Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.Advances in oral delivery of anti-cancer prodrugs.Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: cancer therapy by circumventing the skin barrier.Immuno-chemotherapeutic platinum(IV) prodrugs of cisplatin as multimodal anticancer agents.Comment on "Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance" by H. Song, W. Li, R. Qi, L. Yan, X. Jing, M. Zheng and H. Xiao, Chem. Commun., 2015, 51, 11493.Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low ToxicityLayer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancerPlatinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions.Platinum (IV) pro-drug conjugated NaYF4 :Yb(3+) /Er(3+) nanoparticles for targeted drug delivery and up-conversion cell imaging.Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what?An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer.Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(iv)–acetamidato complex
P2860
Q26771390-6E165CA6-C633-44BB-8232-68AB26E7CA9BQ28074309-90A9961F-C090-4DA3-A090-41F511C0DBAFQ33615268-812CF3E1-99E9-4400-A315-6A35A462FFEAQ33850523-895487BC-C6C2-4863-A468-9D3E5D8D56B1Q35000093-CCB2F487-D301-4A14-AAB1-57A9E6BA8A1BQ38050063-09A19FB6-3B18-48FE-9962-CE33B1BD1870Q38724009-A5A49F34-AECB-49AB-BA0C-2A1421A3325AQ38791841-BDBA4F25-C715-41DE-95FE-513A10148A96Q38812240-DD1F9D1F-3986-4953-9BF3-23CF03B22118Q38826655-4B24D3DB-0692-4A9C-AF98-ED717DE76947Q38832616-FD2DBB57-9AE4-477B-A6D1-D5C6397F0EDCQ38862820-4C140704-2452-477F-982F-3CEC123F0821Q38985327-926BBC76-6851-4D1B-9BE4-7FAB97175B0BQ38993390-0F3EAEB7-246E-4348-93FE-CA904657F663Q39978440-F5E06A1E-D3E3-485F-AC02-F33826B6A28EQ41132341-CBB1E365-0F25-411E-B1CB-F657CD619294Q41382500-3ADAC146-F90E-4369-9459-2E4D1FC20955Q44653144-C1C50AD5-EC99-4574-B4D5-B7AFD6A0AAF6Q45064469-35E2436E-1F20-4626-834F-D29AD6BF5592Q48350344-50A42F3C-1C9F-43AA-8D54-EFEB18891258Q49563999-D6E0321F-E088-41C7-A103-ED7D549BCE28Q50326340-FCA3F99F-D178-453E-A0FD-17F91355E2BFQ59229058-CAAE3201-0D83-4075-A2DB-DC7B6CFAF3E2
P2860
Anticancer platinum (IV) prodrugs with novel modes of activity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Anticancer platinum (IV) prodrugs with novel modes of activity.
@en
Anticancer platinum
@nl
type
label
Anticancer platinum (IV) prodrugs with novel modes of activity.
@en
Anticancer platinum
@nl
prefLabel
Anticancer platinum (IV) prodrugs with novel modes of activity.
@en
Anticancer platinum
@nl
P2093
P1476
Anticancer platinum (IV) prodrugs with novel modes of activity
@en
P2093
Chee Fei Chin
Daniel Yuan Qiang Wong
Ramasamy Jothibasu
P304
P356
10.2174/156802611798040778
P50
P577
2011-01-01T00:00:00Z